RTGN — RetinalGenix Technologies Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1836295 ·
Last close
$4.00
Market Cap
$75.37M
52W High
$4.00
52W Low
$3.20
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -96,774 | -589,229 | -590,489 | 5,805 | 180 | 2,563,889 |
| Dec 2025 | 0 | — | -622,059 | -623,127 | 21,041 | 14,774 | 2,323,652 |
| Sep 2025 | 0 | — | -567,833 | -568,791 | 7,001 | 92 | 2,179,731 |
| Jun 2025 | 0 | — | -648,348 | -649,418 | 8,388 | 839 | 1,989,553 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-480,341
Investing CF
—
Financing CF
$476,810
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.12
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-18,449,106
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-2,427,469
Pretax Income TTM
$-2,431,825
Interest Exp TTM
$4,356
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -2,424,590 | -2,428,595 | 21,041 | 2,323,652 | — | -558,350 |
| Dec 2024 | 0 | -4,316,987 | -4,320,827 | 14,946 | 1,477,556 | — | -741,936 |
| Dec 2023 | 0 | -2,087,049 | -2,090,889 | 156 | 1,405,813 | — | -451,661 |
| Dec 2022 | 0 | -1,875,961 | -3,913,990 | 294 | 1,069,357 | — | -199,287 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STEX | Streamex Corp. | $74.04M | $0.71 | — |
| NRXS | Neuraxis, INC | $77.98M | $6.25 | — |
| HYPR | Hyperfine, Inc. | $78.83M | $0.94 | — |
| DRIO | DarioHealth Corp. | $70.88M | $7.27 | — |
| SPAI | Safe Pro Group Inc. | $81.86M | $3.97 | — |
News headlines (Yahoo Finance, 1h cache)
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
2026-01-14 11:01 · Yahoo
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
2025-12-09 00:43 · Yahoo
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
2025-10-16 09:01 · Yahoo
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
2025-10-01 10:01 · Yahoo
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
2025-09-25 10:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.